$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
美罗华(利妥昔单抗)效果好吗?
2025-10-19 11:44:20
Check Details
美罗华(利妥昔单抗)疗效如何?
2025-10-19 11:44:20
Check Details
美罗华(利妥昔单抗)获批适应症
2025-10-19 11:44:20
Check Details
美罗华2020年国内上市了吗?
2025-10-19 11:44:20
Check Details
利妥昔单抗治疗白血病疗效怎样?
2025-10-19 11:44:20
Check Details
利妥昔单抗目前获批适应症有什么?
2025-10-19 11:44:20
Check Details
利妥昔单抗(Ristova)进医保了吗?
2025-10-19 11:44:20
Check Details
利妥昔单抗的治疗效果如何?
2025-10-19 11:44:20
Check Details
利妥昔单抗用法及用量
2025-10-19 11:44:20
Check Details
美国血液学协会发布新确诊老年人AML治疗新指南
2025-10-19 11:44:20
Check Details
最新!维奈托克联合阿扎胞苷可延长AML总体生存期!
2025-10-19 11:44:20
Check Details
他比特定治疗白血病疗效怎样呢?
2025-10-19 11:44:20
Check Details
1
2
...
363
364
365
366
367
368
369
...
936
937
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Subcutaneous Isatuximab (Sarclisa) for Multiple Myeloma: A New Administration Option
2
Ponatinib vs. Olverembatinib: A Multidimensional Comparison of Third-Generation BCR-ABL Inhibitors
3
Avatrombopag (Doptelet): Oral TPO-RA for Multiple Thrombocytopenia Types
4
Gilteritinib (Xospata): Precision Oral Targeted Therapy for FLT3-Mutated AML
5
Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD): Efficacy, Side Effects, and Patient Treatment Guide
6
Olutasidenib: Mechanism of Action and Clinical Guide for IDH1-Mutated AML
7
Gilteritinib: Efficacy, Medication Guide and Latest Advances for FLT3-Mutated AML
8
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
9
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
10
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
11
A Key Therapeutic Breakthrough Against T315I-Mutant CML
12
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies